aTyr's lead drug, efzofitimod, just completed enrollment in its phase 3 EFZO-FIT trial for pulmonary sarcoidosis, with ...

Strong, continued tech spending on artificial intelligence should be great news for Marvell's growth prospects.

Shares of Tokyo-based SoftBank Group on Friday (August 8) rose as much as 13% after the company posted strong numbers for the ...

What to know about Trump’s pick for the vacant Fed governor seat, this is at risk as crypto bursts into the mainstream, and ...

There’s a full moon rising in the sign of the water bearer this weekend, and it’s one of the most powerful of 2025. The Full ...

Now, it’s not that tariffs won’t have economic consequences. Indeed, they’re the main reason the Fed hasn’t cut interest rates this year, according to Jerome Powell. In his view — which Opening Bell ...

MobiKwik is tightening costs and chasing profitability, with hopes to turn EBITDA-positive by next couple of quarter, even as ...